Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Capital/Financing Update 2018

Aug 1, 2018

33869_rns_2018-08-01_182d1ed1-55c8-4ec5-a0b7-adc06e1cb042.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Market Announcement

==> picture [33 x 50] intentionally omitted <==

2 August 2018

==> picture [451 x 5] intentionally omitted <==

Admedus Limited – Trading Halt

Description

The securities of Admedus Limited (the ‘Company’) will be placed in trading halt at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Monday, 6 August 2018 or when the announcement is released to the market.

Security Code: AHZ

Issued by

Dale Allen

Senior Adviser, Listings Compliance (Perth)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

2 August 2018 ASX Limited

==> picture [452 x 24] intentionally omitted <==

2 August 2018

Ms Anjuli Sinniah Advisor, Listings Compliance ASX Limited Level 40, Central Park 152-158 St Georges Terrance Perth WA 6000

By Email: [email protected] [email protected]

Dear Anjuli

ADMEDUS LIMITED (ASX: AHZ) – REQUEST FOR TRADING HALT

Admedus Limited (the Company ) requests ASX apply an immediate trading halt to the Company’s securities pending an announcement regarding a capital raising.

The Company requests that the trading halt remain until the earlier of an announcement to the market regarding the above or the commencement of trade on ASX on 6 August 2018.

The Company is not aware of any reason why the trading halt should not be granted.

Yours sincerely

==> picture [163 x 42] intentionally omitted <==

Catherine Costello Company Secretary

Customer Service T 1300 550 310 F 1300 880 398

E: [email protected] W: www.admedus.com Brisbane • Minneapolis Zurich • Singapore

Admedus Limited ABN 35 088 221 078

Registered Office Level 9 301 Coronation Drive Milton QLD 4064

International T: +61 8 9266 0100 F: +61 8 9266 0199